|
Parecoxib
|
DB08439 |
[Parecoxib is a water-soluble and injectable prodrug of valdecoxib. It is marketed as Dynastat in the European Union. Parecoxib is a COX2 selective inhibitor in the same category as celecoxib (Celebrex) and rofecoxib (Vioxx). As it is injectable, it can be used perioperatively when patients are unable to take oral medications. It is approved through much of Europe for short term perioperative pain control much in the same way ketorolac (Toradol) is used in the United States. A letter of non-approval for parecoxib was issued by the FDA in 2005.] |
|
4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID
|
DB07108 |
|
|
Allenrolfea occidentalis pollen
|
DB10759 |
[Allenrolfea occidentalis pollen is the pollen of the Allenrolfea occidentalis plant. Allenrolfea occidentalis pollen is mainly used in allergenic testing.] |
|
(2E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoic acid
|
DB07109 |
|
|
Hymenoclea salsola pollen
|
DB10758 |
[Hymenoclea salsola pollen is the pollen of the Hymenoclea salsola plant. Hymenoclea salsola pollen is mainly used in allergenic testing.] |
|
Baccharis halimifolia pollen
|
DB10757 |
[Baccharis halimifolia pollen is the pollen of the Baccharis halimifolia plant. Baccharis halimifolia pollen is mainly used in allergenic testing.] |
|
Salix lasiolepis pollen
|
DB10752 |
[Salix lasiolepis pollen is the pollen of the Salix lasiolepis plant. Salix lasiolepis pollen is mainly used in allergenic testing.] |
|
Elaeagnus angustifolia pollen
|
DB10751 |
[Elaeagnus angustifolia pollen is the pollen of the Elaeagnus angustifolia plant. Elaeagnus angustifolia pollen is mainly used in allergenic testing.] |
|
Populus nigra pollen
|
DB10750 |
[Populus nigra pollen is the pollen of the Populus nigra plant. Populus nigra pollen is mainly used in allergenic testing.] |
|
PARA-NITROPHENYL 1-THIO-BETA-D-GLUCOPYRANOSIDE
|
DB08430 |
|
|
4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL
|
DB07100 |
|
|
[(3R,4S)-4-HYDROXY-3-METHYL-2-OXOHEXYL]PHOSPHONIC ACID
|
DB08431 |
|
|
THYMIDINE-5'-THIOPHOSPHATE
|
DB08432 |
|
|
PD-0325901
|
DB07101 |
[PD-0325901 has been used in trials studying the treatment and basic science of Melanoma, Solid Tumour, Solid Tumors, Advanced Cancer, and Breast Neoplasms, among others.] |
|
(2S)-2-amino-5-oxo-5-[(4-phenylmethoxyphenyl)amino]pentanoic acid
|
DB07102 |
|
|
phenyl ethenesulfonate
|
DB08433 |
|
|
2-METHYLCARBAMOYL-3-(4-PHOSPHONOOXY-PHENYL)-CYCLOPROPANECARBOXYLIC ACID
|
DB08434 |
|
|
2-(4-METHYLPHENOXY)ETHYLPHOSPHINATE
|
DB07103 |
|
|
N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide
|
DB07115 |
|
|
3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile
|
DB08446 |
|